Page last updated: 2024-09-05

sb 203580 and nonanal

sb 203580 has been researched along with nonanal in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (nonanal)	Trials (nonanal)	Recent Studies (post-2010) (nonanal)
3,489	4	1,137	124	0	81

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bae, MA; Jeong, KS; Kim, YC; Lee, IJ; Soh, Y; Song, BJ	1

Other Studies

1 other study(ies) available for sb 203580 and nonanal

Article	Year
Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Molecular pharmacology, 2000, Volume: 58, Issue:3 Topics: Aldehydes; Animals; Apoptosis; Cell Survival; COS Cells; Cyclic AMP; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; PC12 Cells; Phosphorylation; Pyridines; Rats; Thionucleotides; Time Factors	2000

Article

Year

Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells.

Molecular pharmacology, 2000, Volume: 58, Issue:3

Topics: Aldehydes; Animals; Apoptosis; Cell Survival; COS Cells; Cyclic AMP; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; PC12 Cells; Phosphorylation; Pyridines; Rats; Thionucleotides; Time Factors

2000